uniQure (QURE) Liabilities and Shareholders Equity (2015 - 2026)

uniQure (QURE) recorded quarterly Liabilities and Shareholders Equity of $778.7 million in Q1 2026, down 5.6% quarter-over-quarter from $824.9 million in Q4 2025, and up 28.63% on a YoY basis from $605.4 million in Q1 2025.

uniQure (QURE) Liabilities and Shareholders Equity (2015 - 2026) Analysis & Trends

uniQure's Liabilities and Shareholders Equity history runs 12 years deep, the most recent figure standing at $778.7 million for Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity rose 28.63% year-over-year to $778.7 million; the TTM figure through Mar 2026 stood at $3.1 billion (up 21.2% YoY), while the FY2025 annual figure was $824.9 million, up 48.22% from the prior year.
  • Liabilities and Shareholders Equity was $778.7 million for Q1 2026 at uniQure, down from $824.9 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $942.8 million in Q2 2023 to a low of $556.5 million in Q4 2024.
  • Historically, Liabilities and Shareholders Equity has averaged $733.2 million across 5 years, with a median of $730.8 million in 2024.
  • The sharpest annual moves came in 2022 and 2024: Liabilities and Shareholders Equity jumped 108.09% in 2022, then plunged 33.08% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $705.0 million in 2022, then increased by 17.98% to $831.7 million in 2023, then slumped by 33.08% to $556.5 million in 2024, then soared by 48.22% to $824.9 million in 2025, then retreated by 5.6% to $778.7 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $778.7 million (Q1 2026), $824.9 million (Q4 2025), and $888.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 37.37 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 811.27 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 14.93 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.73 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 23.64 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 33.89 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 12.81 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 26.48 Bn
9 Abivax 91.96 Bn 91.96 Bn - 640.56 Mn
10 uniQure 2.88 Bn 2.88 Bn 3.34 Mn 778.71 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 778.71 Mn
Dec 31, 2025 824.91 Mn
Sep 30, 2025 888.38 Mn
Jun 30, 2025 584.89 Mn
Mar 31, 2025 605.40 Mn
Dec 31, 2024 556.54 Mn
Sep 30, 2024 645.81 Mn
Jun 30, 2024 730.85 Mn
Mar 31, 2024 770.05 Mn
Dec 31, 2023 831.69 Mn
Sep 30, 2023 871.55 Mn
Jun 30, 2023 942.77 Mn
Mar 31, 2023 631.00 Mn
Dec 31, 2022 704.96 Mn
Sep 30, 2022 638.23 Mn
Jun 30, 2022 701.21 Mn
Mar 31, 2022 757.15 Mn
Dec 31, 2021 809.18 Mn
Sep 30, 2021 774.63 Mn
Jun 30, 2021 784.26 Mn